80% of all patient data is unstructured. Notes from a conversation with a GP, the evaluation of a specialist in a university medical centre or even a recommendation from a pharmacist.
Dyne’s $305M offering; Nanobiotix delays Ph2 readout
Dyne Therapeutics expects to net $305M in stock sale: The company on Monday dropped updated stock-moving results for its myotonic dystrophy type 1 and Duchenne